Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Avadel Pharmaceuticals Plc ADR (AVDL)

8.14   -0.38 (-4.46%) 12-05 00:54
Open: 8.53 Pre. Close: 8.52
High: 8.57 Low: 8.05
Volume: 459,324 Market Cap: 477M
Avadel Pharmaceuticals plc operates as a specialty pharmaceutical company in the United States, France, and Ireland. The company primarily develops FT218, which is in a Phase 3 clinical trial for the treatment of narcolepsy patients suffering from excessive daytime sleepiness (EDS) and cataplexy. It also markets three sterile injectable drugs used in the hospital setting, including Akovaz that is indicated for the treatment of clinically important hypotension occurring in the setting of anesthesia; Bloxiverz, a cholinesterase inhibitor indicated for the reversal of the effects of non-depolarizing neuromuscular blocking agents after surgery; and Vazculep, a phenylephrine hydrochloride injection indicated for the treatment of clinically important hypotension. The company was formerly known as Flamel Technologies SA and changed its name to Avadel Pharmaceuticals PLC in January 2017. Avadel Pharmaceuticals plc was incorporated in 2015 and is headquartered in Dublin, Ireland.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 8.626 - 8.709 8.709 - 8.759
Low: 7.88 - 7.985 7.985 - 8.048
Close: 8.02 - 8.19 8.19 - 8.293

Technical analysis

as of: 2021-12-03 4:41:53 PM
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 11.96     One year: 13.54
Support: Support1: 8.05    Support2: 6.70
Resistance: Resistance1: 10.24    Resistance2: 11.59
Pivot: 9.57
Moving Average: MA(5): 8.72     MA(20): 9.94
MA(100): 8.80     MA(250): 8.22
MACD: MACD(12,26): -0.32     Signal(9): -0.06
Stochastic oscillator: %K(14,3): 6.49     %D(3): 6.24
RSI: RSI(14): 28.31
52-week: High: 11.59  Low: 6.29  Change(%): 18.3
Average Vol(K): 3-Month: 76356  10-Days: 31695

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
AVDL has closed above bottom band by 0.8%. Bollinger Bands are 47.7% wider than normal. The large width of the bands suggest high volatility as compared to AVDL's normal range. The bands have been in this wide range for 2 bars. This is a sign that the current trend might continue.

Headline News

Mon, 08 Nov 2021
$AVDL Avadel Pharmaceuticals Provides Corporate Update And Reports Third Quarter 2021 Financial Results - CML News

Sun, 08 Aug 2021
The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight - Markets Insider

Tue, 15 Dec 2020
Avadel's Xyrem Competitor: A Quick Overview - Seeking Alpha

Wed, 31 Dec 1969

Wed, 31 Dec 1969

Wed, 31 Dec 1969

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Neutral Price to Earnings: Underperform
Return on Equity: Underperform Debt to Equity: Outperform
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Drug Manufacturers—Specialty & Generic
Shares Out. (M) 59
Shares Float (M) 45
% Held by Insiders 1.07
% Held by Institutions 55.99
Shares Short (K) 3,550
Shares Short P. Month (K) 3,730

Stock Financials

EPS -1.060
EPS Est This Year 1.160
EPS Est Next Year 0.250
Book Value (p.s.) 2.030
Profit Margin
Operating Margin
Return on Assets (ttm) -13.0
Return on Equity (ttm) -37.2
Qtrly Rev. Growth
Gross Profit (p.s.) 0.283
Sales Per Share
EBITDA (p.s.) -1.091
Qtrly Earnings Growth
Operating Cash Flow (M) -63
Levered Free Cash Flow (M) -36

Stock Valuations

PE Ratio -7.68
PEG Ratio
Price to Book value 4.01
Price to Sales
Price to Cash Flow -7.59

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.